A case of lithium carbonate abuse. 1988

M O'Boyle, and E Emory

UI MeSH Term Description Entries
D008094 Lithium An element in the alkali metals family. It has the atomic symbol Li, atomic number 3, and atomic weight [6.938; 6.997]. Salts of lithium are used in treating BIPOLAR DISORDER. Lithium-7,Lithium 7
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002110 Caffeine A methylxanthine naturally occurring in some beverages and also used as a pharmacological agent. Caffeine's most notable pharmacological effect is as a central nervous system stimulant, increasing alertness and producing agitation. It also relaxes SMOOTH MUSCLE, stimulates CARDIAC MUSCLE, stimulates DIURESIS, and appears to be useful in the treatment of some types of headache. Several cellular actions of caffeine have been observed, but it is not entirely clear how each contributes to its pharmacological profile. Among the most important are inhibition of cyclic nucleotide PHOSPHODIESTERASES, antagonism of ADENOSINE RECEPTORS, and modulation of intracellular calcium handling. 1,3,7-Trimethylxanthine,Caffedrine,Coffeinum N,Coffeinum Purrum,Dexitac,Durvitan,No Doz,Percoffedrinol N,Percutaféine,Quick-Pep,Vivarin,Quick Pep,QuickPep
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016651 Lithium Carbonate A lithium salt, classified as a mood-stabilizing agent. Lithium ion alters the metabolism of BIOGENIC MONOAMINES in the CENTRAL NERVOUS SYSTEM, and affects multiple neurotransmission systems. CP-15,467-61,Dilithium Carbonate,Eskalith,Lithane,Lithium Bicarbonate,Lithobid,Lithonate,Lithotabs,Micalith,NSC-16895,Priadel,Quilinorm-retard,Bicarbonate, Lithium,CP 15,467 61,CP15,46761,Carbonate, Dilithium,Carbonate, Lithium,NSC 16895,NSC16895,Quilinorm retard,Quilinormretard
D019966 Substance-Related Disorders Disorders related to substance use or abuse. Chemical Dependence,Drug Abuse,Drug Addiction,Drug Dependence,Drug Habituation,Drug Use Disorder,Drug Use Disorders,Organic Mental Disorders, Substance-Induced,Substance Abuse,Substance Dependence,Substance Related Disorder,Substance Use,Substance Use Disorder,Substance Use Disorders,Prescription Drug Abuse,Substance Addiction,Abuse, Drug,Abuse, Prescription Drug,Abuse, Substance,Addiction, Drug,Addiction, Substance,Chemical Dependences,Dependence, Chemical,Dependence, Drug,Dependence, Substance,Dependences, Chemical,Disorder, Drug Use,Disorder, Substance Related,Disorder, Substance Use,Disorders, Substance Related,Drug Abuse, Prescription,Habituation, Drug,Organic Mental Disorders, Substance Induced,Related Disorder, Substance,Related Disorders, Substance,Substance Abuses,Substance Uses,Use, Substance

Related Publications

M O'Boyle, and E Emory
February 1975, Diseases of the nervous system,
M O'Boyle, and E Emory
November 1972, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
M O'Boyle, and E Emory
January 1975, JAMA,
M O'Boyle, and E Emory
November 1980, The Journal of clinical psychiatry,
M O'Boyle, and E Emory
January 1972, European journal of toxicology,
M O'Boyle, and E Emory
December 1969, Diseases of the nervous system,
M O'Boyle, and E Emory
October 1979, Activitas nervosa superior,
M O'Boyle, and E Emory
March 1977, The Journal of nervous and mental disease,
M O'Boyle, and E Emory
February 1989, The American journal of psychiatry,
M O'Boyle, and E Emory
February 1995, Nihon rinsho. Japanese journal of clinical medicine,
Copied contents to your clipboard!